$1.80
0.55% today
Nasdaq, Nov 20, 08:37 pm CET
ISIN
US0053291078
Symbol
ADAG

Adagene Inc - ADR Stock price

$1.81
-0.09 4.74% 1M
+0.04 2.26% 6M
-0.18 9.05% YTD
-0.41 18.47% 1Y
+0.76 72.38% 3Y
-28.18 93.96% 5Y
-28.18 93.96% 10Y
-28.18 93.96% 20Y
Nasdaq, Closing price Wed, Nov 19 2025
-0.17 8.74%
ISIN
US0053291078
Symbol
ADAG
Industry

Key metrics

Basic
Market capitalization
$93.5m
Enterprise Value
$37.3m
Net debt
positive
Cash
$62.8m
Shares outstanding
58.9m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
934.8 | 12.1
EV/Sales
372.9 | 4.8
EV/FCF
negative
P/B
2.5
Financial Health
Equity Ratio
56.6%
Return on Equity
-66.2%
ROCE
-87.7%
ROIC
231.4%
Debt/Equity
0.2
Financials (TTM | estimate)
Revenue
$100.0k | $7.8m
EBITDA
$-32.8m | $-31.9m
EBIT
$-33.3m | $-34.0m
Net Income
$-29.9m | $-34.1m
Free Cash Flow
$-27.5m
Growth (TTM | estimate)
Revenue
-87.8% | 7,652.0%
EBITDA
10.4% | 9.5%
EBIT
9.9% | 5.6%
Net Income
6.2% | -2.0%
Free Cash Flow
-105.2%
Margin (TTM | estimate)
Gross
-
EBITDA
-31,749.3% | -411.2%
EBIT
-32,284.9%
Net
-28,962.8% | -439.9%
Free Cash Flow
-26,628.0%
More
EPS
$-0.5
FCF per Share
$-0.5
Short interest
0.1%
Employees
138
Rev per Employee
$0.0
Show more

Is Adagene Inc - ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,048 stocks worldwide.

Adagene Inc - ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Adagene Inc - ADR forecast:

8x Buy
73%
3x Hold
27%

Analyst Opinions

11 Analysts have issued a Adagene Inc - ADR forecast:

Buy
73%
Hold
27%

Financial data from Adagene Inc - ADR

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
0.10 0.10
88% 88%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 7.35 7.35
6% 6%
7,350%
- Research and Development Expense 26 26
13% 13%
26,070%
-33 -33
10% 10%
-32,770%
- Depreciation and Amortization 0.55 0.55
38% 38%
550%
EBIT (Operating Income) EBIT -33 -33
10% 10%
-33,318%
Net Profit -30 -30
6% 6%
-29,890%

In millions USD.

Don't miss a Thing! We will send you all news about Adagene Inc - ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Adagene Inc - ADR Stock News

Neutral
GlobeNewsWire
7 days ago
SAN DIEGO and SUZHOU, China and SPRING HOUSE, Pa., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG) and Third Arc Bio, Inc. (“Third Arc Bio”), today announced a licensing agreement under which Third Arc Bio will utilize Adagene's SAFEbody technology platform to generate masked CD3 T cell engagers against unique tumor associated antigens. Under the terms of the agreement...
Neutral
GlobeNewsWire
20 days ago
Phase 2 clinical trial underway with first patient dosed in October to support a clear path to Phase 3 based on  previous alignment with FDA
Neutral
GlobeNewsWire
2 months ago
SAN DIEGO and SUZHOU, China, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG) today announced an amendment to the 2021 collaboration and license agreement with Exelixis. Under the terms of the amended agreement, Exelixis will utilize Adagene's SAFEbody technology platform to generate a masked monoclonal antibody from the company's pipeline for the development of an ant...
More Adagene Inc - ADR News

Company Profile

Adagene, Inc. engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody. The company was founded by Ge Li and Pei Zhi Luo on February 25, 2011 and is headquartered in Suzhou, China.

Head office Cayman Islands
CEO Peizhi Luo
Employees 138
Founded 2011
Website www.adagene.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today